Jason B. Shandell, President and General Counsel at Amphastar Pharmaceuticals, Inc. (AMPH), sold 88,184 shares at $20.37 ($1.8M) on 2019-03-14, disclosed to the SEC on 2019-03-18.
Seasonal sale ($1.8M) by President and General Counsel — this insider has traded AMPH in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.37 | 7,828 | $159K | 8.9% |
| 2 | $20.37 | 7,828 | $159K | 8.9% |
| 3 | $20.23 | 5,255 | $106K | 5.9% |
| 4 | $20.34 | 24,508 | $498K | 27.8% |
| 5 | $20.34 | 24,508 | $498K | 27.8% |
| 6 | $20.23 | 8,381 |
| $170K |
| 9.5% |
| 7 | $20.23 | 9,876 | $200K | 11.2% |
| Total | $20.32 avg | 88,184 | $1.8M | 100% |
| Filing → |
| AMPH | SELL | 2019-12-20 | $314K | — | Filing → |
| AMPH | SELL | 2019-09-20 | $313K | — | Filing → |
| AMPH | SELL | 2019-07-12 | $269K | — | Filing → |